| Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ... Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008 | 6244 | 2008 |
| Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial A Williams, S Gill, T Varma, C Jenkinson, N Quinn, R Mitchell, R Scott, ... The Lancet Neurology 9 (6), 581-591, 2010 | 842 | 2010 |
| Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open … PD Med Collaborative Group The Lancet 384 (9949), 1196-1205, 2014 | 422 | 2014 |
| Gray’s anatomy: the anatomical basis of clinical practice S Susan London, Elsevier Churchill Livingstone Publishers 277, 279, 2005 | 280 | 2005 |
| King's Parkinson's disease pain scale, the first scale for pain in PD: an international validation KR Chaudhuri, A Rizos, C Trenkwalder, O Rascol, S Pal, D Martino, ... Movement Disorders 30 (12), 1623-1631, 2015 | 262 | 2015 |
| Bilateral globus pallidus stimulation for severe Tourette's syndrome: a double-blind, randomised crossover trial Z Kefalopoulou, L Zrinzo, M Jahanshahi, J Candelario, C Milabo, M Beigi, ... The Lancet Neurology 14 (6), 595-605, 2015 | 176 | 2015 |
| Small fiber neuropathy in Parkinson's disease: a clinical, pathological and corneal confocal microscopy study L Kass-Iliyya, S Javed, D Gosal, C Kobylecki, A Marshall, IN Petropoulos, ... Parkinsonism & related disorders 21 (12), 1454-1460, 2015 | 154 | 2015 |
| Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study F McGill, MJ Griffiths, LJ Bonnett, AM Geretti, BD Michael, NJ Beeching, ... The Lancet Infectious Diseases 18 (9), 992-1003, 2018 | 147 | 2018 |
| EuroInf 2: subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease HS Dafsari, P Martinez‐Martin, A Rizos, M Trost, MG dos Santos Ghilardi, ... Movement disorders 34 (3), 353-365, 2019 | 143 | 2019 |
| Discovery of volatile biomarkers of Parkinson’s disease from sebum DK Trivedi, E Sinclair, Y Xu, D Sarkar, C Walton-Doyle, C Liscio, P Banks, ... ACS central science 5 (4), 599-606, 2019 | 141 | 2019 |
| Non-motor outcomes depend on location of neurostimulation in Parkinson’s disease JN Petry-Schmelzer, M Krause, TA Dembek, A Horn, J Evans, K Ashkan, ... Brain 142 (11), 3592-3604, 2019 | 115 | 2019 |
| Beneficial effects of bilateral subthalamic stimulation on non-motor symptoms in Parkinson's disease HS Dafsari, P Reddy, C Herchenbach, S Wawro, JN Petry-Schmelzer, ... Brain stimulation 9 (1), 78-85, 2016 | 112 | 2016 |
| Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease E Sinclair, DK Trivedi, D Sarkar, C Walton-Doyle, J Milne, T Kunath, ... Nature communications 12 (1), 1592, 2021 | 108 | 2021 |
| A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease MA Silverdale, C Kobylecki, L Kass-Iliyya, P Martinez-Martin, M Lawton, ... Parkinsonism & related disorders 56, 27-32, 2018 | 108 | 2018 |
| Physiotherapy and occupational therapy vs no therapy in mild to moderate Parkinson disease: a randomized clinical trial CE Clarke, S Patel, N Ives, CE Rick, F Dowling, R Woolley, K Wheatley, ... JAMA neurology 73 (3), 291-299, 2016 | 97 | 2016 |
| A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short‐and long‐acting dopamine agonists A Rizos, A Sauerbier, A Antonini, D Weintraub, P Martinez‐Martin, ... European journal of neurology 23 (8), 1255-1261, 2016 | 91 | 2016 |
| Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson's disease MA Silverdale, S McGuire, A McInnes, AR Crossman, JM Brotchie Experimental neurology 169 (2), 400-406, 2001 | 91 | 2001 |
| Non‐motor symptoms burden in treated and untreated early Parkinson's disease patients: argument for non‐motor subtypes P Zis, P Martinez‐Martin, A Sauerbier, A Rizos, JC Sharma, PF Worth, ... European journal of neurology 22 (8), 1145-1150, 2015 | 89 | 2015 |
| Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate MA Silverdale, C Kobylecki, PJ Hallett, Q Li, AW Dunah, P Ravenscroft, ... Synapse 64 (2), 177, 2010 | 85 | 2010 |
| Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease HS Dafsari, M Silverdale, M Strack, A Rizos, K Ashkan, P Mahlstedt, ... Movement Disorders 33 (3), 421-430, 2018 | 83 | 2018 |
